Lantheus Holdings, Inc. Additional Paid in Capital, Common Stock
Lantheus Holdings, Inc. (LNTH) had Additional Paid in Capital, Common Stock of $917.71 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $917.71M.
- 2026-03-31: Additional Paid in Capital, Common Stock $892.95M.
- 2025-12-31: Additional Paid in Capital, Common Stock $888.32M.
- 2025-09-30: Additional Paid in Capital, Common Stock $871.19M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $917.71M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $892.95M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $888.32M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $871.19M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $844.90M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $821.35M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $817.97M 10-K · filed 2026-02-26 |
| 2024-09-30 | $797.43M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $775.54M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $756.44M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $757.73M 10-K · filed 2025-02-26 |
| 2023-09-30 | $743.97M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $729.73M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $717.16M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $715.88M 10-K · filed 2024-02-22 |
| 2022-09-30 | $708.34M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $699.53M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $691.52M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $685.47M 10-K · filed 2023-02-23 |
| 2021-09-30 | $680.82M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $676.06M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $669.62M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $665.53M 10-K · filed 2022-02-24 |
| 2020-09-30 | $661.96M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $657.67M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $253.53M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $251.64M 10-K · filed 2021-02-25 |
| 2019-09-30 | $248.69M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $244.60M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $242.07M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $239.87M 10-K · filed 2020-02-25 |
| 2018-09-30 | $237.59M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $235.88M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $234.76M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $232.96M 10-K · filed 2019-02-20 |
| 2017-09-30 | $228.93M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $228.08M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $227.68M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $226.46M 10-K · filed 2018-02-26 |
| 2016-09-30 | $216.81M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $176.54M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $175.96M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $175.55M 10-K · filed 2017-02-23 |
| 2015-09-30 | $175.07M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $174.58M 10-Q · filed 2015-08-05 |
| 2014-12-31 | $106.70M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |